Head and neck cancer

You have access
Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation
YASUSHI SAMUKAWA, YOHEI OUCHI, TAKENORI MIYASHITA, ASADUR RAHMAN, IKUKO TSUKAMOTO, AKIHIDE YOSHIHARA and HIROSHI HOSHIKAWA

Anticancer Research May 2024, 44 (5) 1895-1903; DOI: https://doi.org/10.21873/anticanres.16991
Open Access
Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study
JOSEFINE BAUDREXL, ANDREAS SAKKAS, SEBASTIAN PIETZKA, SPYRIDOULA DERKA, GEORGIA VAIRAKTARI, MARIO SCHEURER, ALEXANDER SCHRAMM, FRANK WILDE and MARCEL EBELING

Anticancer Research March 2024, 44 (3) 1247-1270; DOI: https://doi.org/10.21873/anticanres.16921
Open Access
Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma – A Meta-analysis
DAISY EDEN, ARUNI GHOSE, MICHELE MOSCHETTA, JOSÉ ALEJANDRO PÉREZ-FIDALGO, ELIE RASSY and STERGIOS BOUSSIOS

Anticancer Research March 2024, 44 (3) 861-878; DOI: https://doi.org/10.21873/anticanres.16880
You have access
Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer
JOSEFINE BAUDREXL, SEBASTIAN PIETZKA, MARIO SCHEURER, ALEXANDER SCHRAMM, FRANK WILDE, ANDREAS SAKKAS, SPYRIDOULA DERKA and MARCEL EBELING

Anticancer Research January 2024, 44 (1) 267-286; DOI: https://doi.org/10.21873/anticanres.16810
You have access
Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB–VMAT
NAHOMI YOSHIMURA, MASAYUKI FUJIWARA, MASATAKA IGETA, HITOMI SUZUKI, RYO KUNIMOTO, TOMONORI TERADA, YUICHIRO SHINODA, MASATAKA NAKAMURA, JUNKO FUKUTAKE, HARUYUKI TAKAKI and KOICHIRO YAMAKADO

Anticancer Research January 2024, 44 (1) 323-329; DOI: https://doi.org/10.21873/anticanres.16815
Open Access
Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality
SETH BURYSKA, KETAN PATEL, BEVERLY WUERTZ, PATRICK M. GAFFNEY and FRANK ONDREY

Anticancer Research December 2023, 43 (12) 5299-5310; DOI: https://doi.org/10.21873/anticanres.16733
You have access
Correlation of Intra-tumoral and Peripheral PD-1/PD-L1 Immunity in Head and Neck Cancer
CHRISTIAN IDEL, JULIKA RIBBAT-IDEL, AMELIE VON BERNUTH, JONAS FLECKNER, DIRK RADES, JUTTA KIRFEL, VERENA SAILER, KIRSTIN PLÖTZE-MARTIN, KARL-LUDWIG BRUCHHAGE and RALPH PRIES

Anticancer Research December 2023, 43 (12) 5349-5358; DOI: https://doi.org/10.21873/anticanres.16738
Open Access
Development of Distress During a Radiotherapy Course for Head-and-neck Cancer
DIRK RADES, CANSU DELIKANLI, NATHAN Y. YU and STEFAN JANSSEN

Anticancer Research September 2023, 43 (9) 4149-4153; DOI: https://doi.org/10.21873/anticanres.16605
You have access
Malnutrition in Head and Neck Cancer: A Patient-reported Outcome Study
ANDREAS COFRÉ, STEFANIE WALTER, JENS BUENTZEL and JUTTA HÜBNER

Anticancer Research April 2023, 43 (4) 1663-1673; DOI: https://doi.org/10.21873/anticanres.16318
You have access
Real-world Data Study of the Efficacy and Toxicity of Nivolumab vs. Cetuximab and Predictors of Response to Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck in a European Population
LOLA MACIA-RIVAS, CLARA LUZ FERNANDEZ-LAGUNA, CRISTINA ALVAREZ-ASTEINZA, IVAN MARAY, MONICA CARBAJALES-ALVAREZ and ANA LOZANO-BLAZQUEZ

Anticancer Research April 2023, 43 (4) 1681-1688; DOI: https://doi.org/10.21873/anticanres.16320

Main menu

User menu

Search

Head and neck cancer

Pages